Two more pharmaceutical companies have added teams for this year's Rare Cancers Australia Mount Kosciuszko Challenge.
Merck and Amgen, who both participated last year, have signed up for the 2018 challenge that will take place on Saturday 17 March - St Patrick's Day.
Registrations are still open for the challenge that will see hundreds of people climbing Australia's highest mountain.
The 2017 challenge raised $150,000 for Rare Cancers Australia and the organisation is well on track to reach this year's goal of $200,000. It has just passed $125,000 with over two weeks to go.
Industry will again compete for the 'Pharma 2 Peak Kosi Challenge' cup, sponsored by PharmaDispatch, which last year was won by the 'MSD Mountaineers'.
The holders are ahead in the race for 2018, having so far raised almost $10,000, placing them second behind overall team leader High Camp, which has so far raised over $28,000.
Other companies are starting to add to their fundraising tally, with the Abbvie Kozi Klimbers, Gilead Goes Climbing, AstraZeneca Azcends, Janssen Kosi Climbers, Novartis and Bayer Bullets, adding to their totals.
The 'Pharma 2 Peak Kosi Challenge' cup will be presented at the event dinner, following the challenge, on Saturday 17 March
To view the original article in PharmaDispatch click here